Firm News | January 8, 2026
Gibson Dunn is advising Jefferies LLC as lead financial advisor to Ventyx Biosciences, Inc. on Ventyx Biosciences’ approximately $1.2 billion sale to Eli Lilly and Company.
The Gibson Dunn corporate team is led by partners Ryan Murr and Sebastian Fain and includes associates Ashley Whittington and Muriel Hague.